Insider Shareholders with Direct Ownership of Akoya Biosciences, Inc. (AKYA)
This section provides a comprehensive overview of the insiders with direct ownership of Akoya Biosciences, Inc. (AKYA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Akoya Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Matthew Winkler
Director |
203,388 | 0 | 984,513 $2.69 Million | 1 |
Jun 12, 2023
Added 17.12%
|
|
Garry Ph.D. Nolan
Director |
0 | 88,206 | 591,978 $1.62 Million | 11 |
Dec 02, 2022
Reduced 0.19%
|
|
Joseph Driscoll
Chief Financial Officer |
287,113 | 24,613 | 262,500 $716,625 | 4 |
Dec 22, 2022
Added 48.78%
|
|
Brian Mc Kelligon
President and CEO |
317,500 | 102,316 | 224,733 $613,521 | 29 |
Jun 11, 2024
Reduced 3.23%
|
|
Niro Ph.D Ramachandran
Chief Business Officer |
214,180 | 6,256 | 207,924 $567,632 | 10 |
Mar 23, 2024
Reduced 0.96%
|
| 195,000 | 14,272 | 180,728 $493,387 | 3 |
Apr 01, 2024
Reduced 7.32%
|
|
|
Pascal Bamford
Chief Clinical Officer |
40,000 | 0 | 122,758 $335,129 | 1 |
Aug 29, 2024
Added 24.58%
|
|
Frederic Pla
Chief Operating Officer |
107,500 | 6,000 | 101,500 $277,095 | 7 |
Mar 23, 2024
Reduced 1.94%
|
|
Jennifer Kamocsay
General Counsel |
102,500 | 3,283 | 99,217 $270,862 | 4 |
Mar 01, 2024
Reduced 3.2%
|
|
Robert G Shepler
Director |
35,000 | 0 | 35,000 $95,550 | 1 |
Nov 18, 2021
Added 36.36%
|
|
Scott Mendel
Director |
28,500 | 0 | 28,500 $77,805 | 2 |
Jun 12, 2023
Added 41.24%
|
|
Goldman Myla Lai
Director |
20,000 | 0 | 20,000 $54,600 | 1 |
Jun 12, 2023
Added 50.0%
|
|
Marilee Moy
CHIEF PEOPLE OFFICER |
20,000 | 0 | 20,000 $54,600 | 1 |
Feb 23, 2023
Added 50.0%
|
|
Ehab El Gabry
Chief Medical Officer |
16,250 | 0 | 16,250 $44,362 | 1 |
Feb 23, 2023
Added 50.0%
|